[1]CurrentPatentAssignee:ARAXESPHARMALLC-WO2018/68017,2018,A1Locationinpatent:Page/Pagecolumn144
137467-21-1
1354940-69-4
1212304-86-3
45125-00-6
1119-33-1
58640-01-0
114473-81-3 | 2,4-Pyrrolidinedione, 1-phenyl- | AA000EEW | MFCD20482733
114745-26-5 | 5'-O-Dmt-n2-isobutyryl-2'-o-methyl-d-guanosine | AA000F25 | MFCD09842119
114971-52-7 | Benzyltrimethylammonium dichloroiodate | AA000FG0 | MFCD00075259
1150271-26-3 | Methyl 2,5-dibromofuran-3-carboxylate | AA000FM7 | MFCD12026056
115070-62-7 | 7-(Chloromethyl)-2,2-dimethyl-2,3-dihydrobenzofuran | AA000FSA | MFCD08060501
115103-54-3 | Tiagabine | AA000G86 | MFCD00865317
115309-57-4 | 6-Chloronicotinic acid tert-butyl ester | AA000GIA | MFCD08277247
1158763-56-4 | 5-(2-Fluorophenyl)picolinic acid | AA000GXU | MFCD12406463
115964-29-9 | Tosufloxacin tosilate | AA000H5X | MFCD01711971
1190310-24-7 | Methyl 5-fluoro-1h-pyrrolo[2,3-b]pyridine-4-carboxylate | AA000HDM | MFCD12962823